Division of Endocrinology, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand.
Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, 40002, Thailand.
Sci Rep. 2024 Sep 28;14(1):22404. doi: 10.1038/s41598-024-74463-9.
T2DM (Type 2 Diabetes Mellitus) patients with vertebral fractures have a higher mortality rate than non-DM (nondiabetic patients). However, the prevalence of vertebral fractures in the Asian diabetic population is not well established. Moreover, despite an apparent increase in fracture risk in patients with diabetes, Asian countries have provided contradictory data demonstrating that bone mineral density (BMD) varies significantly in T2DM patients. The aim of this study was to examine and compare the prevalence of vertebral fractures and osteoporosis, as well as BMD and the FRAX score, between individuals with and without T2DM and assess the association of these factors with vertebral fractures. Postmenopausal Thai women attending diabetic and health check-up clinics were recruited. BMD at the lumbar spine, total hip, and femoral neck was measured via dual-energy X-ray absorptiometry. A morphometric vertebral fracture (VF) was defined by a lateral thoracolumbar (T-L) X-ray radiograph. The Fracture Risk Assessment Tool (FRAX) was used to calculate the 10-year probabilities of hip and major osteoporotic fracture (MOF), which were calculated on the basis of the Thai FRAX model. A total of 435 participants were recruited, including 145 postmenopausal women with T2DM and 290 non-DM individuals. T2DM patients had a significantly greater BMI (p = 0.006) and BMD at the femoral neck (p = 0.024) and total hip (p = 0.017), but there was no significant difference in the FRAX score, including the 10-year probability of hip fracture or MOF, either with or without BMD, between individuals with and without T2DM. The prevalence of osteoporosis in non-DM women was significantly higher at the femoral neck (OR = 0.56, 95% CI: 0.34 to 0.93, p = 0.029) but comparable at the lumbar spine. Individuals with T2DM had a significantly higher rate of vertebral fractures, particularly those involving two or more levels, than those without T2DM. Diabetes was significantly associated with [Formula: see text]2 VF (OR = 3.83, 95% CI: 1.77 to 8.28, p = 0.001), and the association remained unchanged after controlling for other clinical factors (adjusted OR = 3.72, 95% CI 1.70-8.15; p = 0.001). Our study demonstrated a greater prevalence of multiple ([Formula: see text] two levels) VFs in women with T2DM than in non-DM controls.
2 型糖尿病(T2DM)合并椎体骨折患者的死亡率高于非糖尿病患者(非 DM 患者)。然而,亚洲糖尿病患者椎体骨折的患病率尚未得到充分证实。此外,尽管糖尿病患者的骨折风险明显增加,但亚洲国家提供的数据相互矛盾,表明 T2DM 患者的骨密度(BMD)差异很大。本研究旨在检查和比较 T2DM 患者和非 T2DM 患者的椎体骨折和骨质疏松症的患病率,以及 BMD 和 FRAX 评分,并评估这些因素与椎体骨折的相关性。招募了参加糖尿病和健康检查诊所的绝经后泰国女性。通过双能 X 射线吸收法测量腰椎、全髋和股骨颈的 BMD。通过侧位胸腰椎(T-L)X 射线片定义形态学椎体骨折(VF)。使用骨折风险评估工具(FRAX)计算髋部和主要骨质疏松性骨折(MOF)的 10 年概率,这些概率是基于泰国 FRAX 模型计算的。共纳入 435 名参与者,包括 145 名绝经后 T2DM 患者和 290 名非 DM 个体。T2DM 患者的 BMI(p=0.006)和股骨颈(p=0.024)及全髋(p=0.017)的 BMD 显著更高,但无论是否存在 BMD,T2DM 患者的 FRAX 评分,包括髋部骨折或 MOF 的 10 年概率,在 T2DM 患者和非 T2DM 患者之间均无显著差异。非 DM 女性的股骨颈骨质疏松症患病率明显更高(OR=0.56,95%CI:0.34-0.93,p=0.029),但腰椎相似。与非 T2DM 患者相比,T2DM 患者的椎体骨折发生率显著更高,特别是涉及两个或更多水平的骨折。糖尿病与 2 个及以上水平的[Formula: see text]2 VF 显著相关(OR=3.83,95%CI:1.77-8.28,p=0.001),且在控制其他临床因素后相关性仍然不变(调整 OR=3.72,95%CI 1.70-8.15;p=0.001)。我们的研究表明,与非 DM 对照组相比,T2DM 女性的多发性([Formula: see text]2 个水平)VF 患病率更高。